Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Real-World study tests safety of new heart stents

NCT ID NCT02593994

Disease control Sponsor: Seung-Jung Park Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how well Onyx drug-eluting stents work in everyday medical practice for people with coronary artery disease. Researchers will track 4,500 patients to see if these stents are safe and effective compared to other stents. The main focus is on preventing stent-related blood clots and other heart problems.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Onyx drug-eluting stent
What this could lead to
If successful, this could confirm that Onyx stents are a safe and effective option for treating blocked arteries in real-world patients.
What could go wrong
This is an observational study, not a controlled trial, so results may be less definitive. Stent thrombosis or other complications remain possible risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

4,500 people

The number who actually took part.

Started

Oct 2015

Expected to finish

Dec 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

patients with Onyx Drug Eluting Stent

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 19 and more * Intervention with Onyx Drug Eluting Stent * Agreed with written informed consent form Exclusion Criteria: * Intervention with Onyx drug eluting coronary stent and other drug eluting stent at the same time * Life expectancy of 1year and under * Cardiac shock

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arterial occlusive diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Arterial Occlusive Diseases cardiovascular disorder coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Arterial occlusive diseases Cardiovascular diseases Coronary artery disease Percutaneous transluminal angioplasty

Contacts and locations

Locations

  • Asan Medical Center

    Seoul, Songpa-gu, 138-736, South Korea

  • Bundang CHA Hospital

    Seongnam, South Korea

  • Chonnam National University Hospital

    Gwangju, South Korea

  • Chungnam National University Hospital

    Daejeon, South Korea

  • Daegu Catholic University Medical Center

    Daegu, South Korea

  • Dong-A Medical Center

    Pusan, South Korea

  • Gangnam Severance Hospital

    Seoul, South Korea

  • Gangneung Asan Hospital

    Gangneung, South Korea

  • Gangwon National Univ. Hospital

    Chuncheon, South Korea

  • Hallym University Kangnam Sacred Heart Hospital

    Seoul, South Korea

  • Hallym University Sacred Heart Hospital

    Anyang, South Korea

  • Inje University Ilsan Paik Hospital

    Ilsan, South Korea

  • Inje University Pusan Paik Hospital

    Pusan, South Korea

  • Kangbuk Samsung Hospital

    Seoul, South Korea

  • Kangdong Sacred Heart Hospital

    Seoul, South Korea

  • Keimyung University Dongsan Medical Center

    Daegu, South Korea

  • Korea University Anam Hospital

    Seoul, South Korea

  • Korea University Guro Hospital

    Seoul, South Korea

  • Kwangju Christian Hospital

    Kwangju, South Korea

  • Presbyterian Medical Center

    Jeonju, South Korea

  • Pusan National University Hospital

    Pusan, South Korea

  • Pusan National University Yangsan Hospital

    Yangsan, South Korea

  • Soon Chun Hyang University Hospital Bucheon

    Bucheon-si, South Korea

  • Soon Chun Hyang University Hospital Cheonan

    Cheonan, South Korea

  • St.carollo Hospital

    Suncheon, South Korea

  • The Catholic University of Korea Seoul St. Mary's Hospital

    Seoul, South Korea

  • The Catholic University of Korea St. Paul's Hospital

    Seoul, South Korea

  • The Catholic University of Korea, Daejeon ST. Mary's Hospital

    Daejeon, South Korea

  • The Catholic University of Korea, Yeouido St. Mary's Hospital

    Seoul, Republic of Korea, South Korea

  • Ulsan University Hospital

    Ulsan, South Korea

  • Wonju Severance Christian Hospital

    Wŏnju, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.